Koyfin Home > Directory > Health Care > Abbott Laboratories > Cost of Goods Sold

Abbott Laboratories Cost of Goods Sold Chart (ABT)

Abbott Laboratories annual/quarterly Cost of Goods Sold from 2010 to 2020.
  • Abbott Laboratories Cost of Goods Sold for the quarter ending September 09, 2020 was $3,966m a 13.59% increase of 539m year over year
  • Abbott Laboratories Cost of Goods Sold for the last 12 months ending September 09, 2020 was $13,902m a 5.08% increase of 706m year over year
  • Abbott Laboratories Annual Cost of Goods Sold for 2019 was $13,196m a 4.07% increase of 537m from 2018
  • Abbott Laboratories Annual Cost of Goods Sold for 2018 was $12,659m a 9.23% increase of 1,169m from 2017
  • Abbott Laboratories Annual Cost of Goods Sold for 2017 was $11,490m a 20.93% increase of 2,405m from 2016
Other Income Statement Metrics:
  • Abbott Laboratories EBITDA for the quarter ending December 12, 2018 was $1,978m a 22.30% increase of 441m year over year
  • Abbott Laboratories Net Income for the quarter ending December 12, 2018 was $654m a 36.09% increase of 236m year over year
  • Abbott Laboratories Total Revenue for the quarter ending December 12, 2018 was $7,765m a 4.83% increase of 375m year over year
View Chart On Koyfin

Quarterly ABT Cost of Goods Sold Data

09/2020$3,966m
06/2020$3,263m
03/2020$3,277m
12/2019$3,427m
09/2019$3,358m
06/2019$3,279m
03/2019$3,160m
12/2018$3,144m
09/2018$3,166m
06/2018$3,282m

Annual ABT Cost of Goods Sold Data

2019$13,196m
2018$12,659m
2017$11,490m
2016$9,085m
2015$8,729m
2014$9,191m
2013$9,168m
2012$8,851m
2011$9,971m
2010$14,510m